Concepts (175)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Gastroenterology | 5 | 2024 | 593 | 2.060 |
Why?
|
Helicobacter pylori | 5 | 2024 | 380 | 1.210 |
Why?
|
Helicobacter Infections | 4 | 2024 | 390 | 1.110 |
Why?
|
Fellowships and Scholarships | 2 | 2024 | 1134 | 1.000 |
Why?
|
Esophageal Neoplasms | 4 | 2021 | 1674 | 0.980 |
Why?
|
Isoprostanes | 2 | 2016 | 21 | 0.960 |
Why?
|
Cholangiopancreatography, Endoscopic Retrograde | 2 | 2024 | 520 | 0.900 |
Why?
|
Zambia | 10 | 2023 | 273 | 0.810 |
Why?
|
Stomach Neoplasms | 6 | 2016 | 1483 | 0.780 |
Why?
|
Peutz-Jeghers Syndrome | 1 | 2022 | 61 | 0.770 |
Why?
|
Jaundice, Obstructive | 1 | 2020 | 22 | 0.720 |
Why?
|
Alcohol Drinking | 4 | 2024 | 4045 | 0.710 |
Why?
|
Choledocholithiasis | 1 | 2020 | 50 | 0.690 |
Why?
|
Adenomatous Polyposis Coli | 1 | 2022 | 219 | 0.690 |
Why?
|
Hamartoma | 1 | 2022 | 236 | 0.670 |
Why?
|
Neoplastic Syndromes, Hereditary | 1 | 2022 | 249 | 0.650 |
Why?
|
Colorectal Neoplasms | 3 | 2024 | 6982 | 0.580 |
Why?
|
Physicians, Primary Care | 1 | 2024 | 625 | 0.570 |
Why?
|
Cholangiocarcinoma | 1 | 2023 | 562 | 0.570 |
Why?
|
Bile Duct Neoplasms | 1 | 2023 | 615 | 0.570 |
Why?
|
Africa | 5 | 2024 | 726 | 0.560 |
Why?
|
Adenocarcinoma | 5 | 2021 | 6401 | 0.500 |
Why?
|
Endemic Diseases | 1 | 2016 | 191 | 0.480 |
Why?
|
Endoscopy, Digestive System | 1 | 2017 | 358 | 0.460 |
Why?
|
Education, Medical, Continuing | 2 | 2022 | 829 | 0.430 |
Why?
|
Conscious Sedation | 1 | 2017 | 534 | 0.400 |
Why?
|
Gastritis, Atrophic | 1 | 2011 | 31 | 0.390 |
Why?
|
Nigeria | 2 | 2024 | 779 | 0.330 |
Why?
|
Epstein-Barr Virus Infections | 2 | 2016 | 617 | 0.330 |
Why?
|
Anesthesiology | 2 | 2017 | 1137 | 0.330 |
Why?
|
Preoperative Care | 1 | 2017 | 2258 | 0.290 |
Why?
|
Hepatitis B | 2 | 2023 | 711 | 0.280 |
Why?
|
Cameroon | 2 | 2024 | 79 | 0.280 |
Why?
|
Health Resources | 1 | 2013 | 951 | 0.270 |
Why?
|
Precancerous Conditions | 2 | 2016 | 985 | 0.260 |
Why?
|
Energy Intake | 1 | 2013 | 2146 | 0.240 |
Why?
|
Antioxidants | 1 | 2013 | 1673 | 0.240 |
Why?
|
Biliary Fistula | 1 | 2024 | 38 | 0.240 |
Why?
|
Nutritional Status | 1 | 2013 | 1627 | 0.230 |
Why?
|
Incidence | 6 | 2024 | 21547 | 0.230 |
Why?
|
Endoscopy, Gastrointestinal | 3 | 2021 | 888 | 0.220 |
Why?
|
Cholangitis | 1 | 2024 | 110 | 0.220 |
Why?
|
Carcinoma, Squamous Cell | 2 | 2016 | 4064 | 0.210 |
Why?
|
Smoking | 4 | 2016 | 9094 | 0.210 |
Why?
|
Amoxicillin | 1 | 2024 | 182 | 0.210 |
Why?
|
Pancreatic Neoplasms | 2 | 2020 | 5443 | 0.210 |
Why?
|
Mass Screening | 1 | 2018 | 5457 | 0.200 |
Why?
|
Cholecystectomy | 1 | 2024 | 409 | 0.200 |
Why?
|
Postoperative Complications | 1 | 2024 | 15889 | 0.200 |
Why?
|
Intestinal Polyps | 1 | 2022 | 105 | 0.190 |
Why?
|
Education, Medical, Graduate | 2 | 2024 | 2422 | 0.190 |
Why?
|
Risk Factors | 13 | 2024 | 74976 | 0.190 |
Why?
|
Bile Ducts, Intrahepatic | 1 | 2023 | 304 | 0.190 |
Why?
|
Proton Pump Inhibitors | 2 | 2024 | 552 | 0.190 |
Why?
|
Peptic Ulcer Hemorrhage | 1 | 2021 | 47 | 0.190 |
Why?
|
Life Style | 4 | 2024 | 3931 | 0.180 |
Why?
|
Middle Aged | 16 | 2024 | 223737 | 0.180 |
Why?
|
Feeding Behavior | 1 | 2013 | 3205 | 0.180 |
Why?
|
Developing Countries | 1 | 2013 | 2911 | 0.180 |
Why?
|
Curriculum | 2 | 2024 | 3782 | 0.180 |
Why?
|
Humans | 30 | 2024 | 768970 | 0.170 |
Why?
|
Young Adult | 7 | 2024 | 60131 | 0.160 |
Why?
|
Male | 19 | 2024 | 365203 | 0.160 |
Why?
|
Female | 20 | 2024 | 397515 | 0.160 |
Why?
|
Risk Assessment | 2 | 2017 | 24333 | 0.150 |
Why?
|
Gastrointestinal Tract | 1 | 2023 | 840 | 0.140 |
Why?
|
South Africa | 1 | 2023 | 1872 | 0.140 |
Why?
|
Perception | 1 | 2023 | 1209 | 0.140 |
Why?
|
Adult | 13 | 2024 | 223851 | 0.140 |
Why?
|
Suburban Population | 1 | 2016 | 54 | 0.140 |
Why?
|
Aged, 80 and over | 5 | 2024 | 59739 | 0.130 |
Why?
|
Prevalence | 7 | 2022 | 15879 | 0.130 |
Why?
|
Aged | 10 | 2024 | 171786 | 0.130 |
Why?
|
Drug Resistance, Bacterial | 1 | 2023 | 1063 | 0.120 |
Why?
|
Esophagectomy | 1 | 2019 | 482 | 0.120 |
Why?
|
Cancer Care Facilities | 1 | 2018 | 428 | 0.120 |
Why?
|
Age Distribution | 1 | 2021 | 2875 | 0.120 |
Why?
|
Diagnostic Techniques, Respiratory System | 1 | 2014 | 13 | 0.120 |
Why?
|
Pancreatic Diseases | 1 | 2017 | 353 | 0.120 |
Why?
|
Deglutition Disorders | 1 | 2021 | 641 | 0.120 |
Why?
|
Neoplasm Staging | 2 | 2021 | 11262 | 0.120 |
Why?
|
Metaplasia | 2 | 2013 | 326 | 0.110 |
Why?
|
Databases, Factual | 2 | 2021 | 8094 | 0.110 |
Why?
|
Hospitals, University | 1 | 2016 | 570 | 0.110 |
Why?
|
Esophagoscopy | 1 | 2016 | 398 | 0.110 |
Why?
|
Africa, Southern | 1 | 2013 | 60 | 0.110 |
Why?
|
Pepsinogen C | 1 | 2013 | 7 | 0.110 |
Why?
|
Antibodies, Helminth | 1 | 2013 | 59 | 0.110 |
Why?
|
Pepsinogen A | 1 | 2013 | 14 | 0.110 |
Why?
|
Gastrins | 1 | 2013 | 75 | 0.110 |
Why?
|
HIV Infections | 5 | 2022 | 17591 | 0.110 |
Why?
|
Smoke | 1 | 2015 | 242 | 0.100 |
Why?
|
Dinoprost | 1 | 2013 | 139 | 0.100 |
Why?
|
United States | 4 | 2024 | 73186 | 0.100 |
Why?
|
Schistosomiasis mansoni | 1 | 2013 | 94 | 0.100 |
Why?
|
Diet | 2 | 2024 | 8088 | 0.100 |
Why?
|
Statistics, Nonparametric | 1 | 2018 | 2862 | 0.100 |
Why?
|
Schistosoma mansoni | 1 | 2013 | 156 | 0.100 |
Why?
|
Gas Chromatography-Mass Spectrometry | 1 | 2013 | 354 | 0.100 |
Why?
|
Hepatitis C | 1 | 2022 | 1595 | 0.100 |
Why?
|
Sex Distribution | 1 | 2016 | 2280 | 0.090 |
Why?
|
Case-Control Studies | 5 | 2016 | 22296 | 0.090 |
Why?
|
Age of Onset | 1 | 2018 | 3346 | 0.090 |
Why?
|
Health Knowledge, Attitudes, Practice | 2 | 2024 | 4056 | 0.090 |
Why?
|
Carcinoma, Hepatocellular | 1 | 2023 | 2336 | 0.090 |
Why?
|
Retrospective Studies | 6 | 2021 | 81903 | 0.090 |
Why?
|
Pancreas | 1 | 2017 | 1700 | 0.090 |
Why?
|
Age Factors | 2 | 2019 | 18435 | 0.090 |
Why?
|
Logistic Models | 2 | 2016 | 13318 | 0.080 |
Why?
|
Public Health | 2 | 2014 | 2680 | 0.080 |
Why?
|
Health Status Indicators | 1 | 2014 | 971 | 0.080 |
Why?
|
Propensity Score | 1 | 2017 | 1968 | 0.080 |
Why?
|
Urban Population | 1 | 2016 | 2046 | 0.080 |
Why?
|
Clinical Competence | 1 | 2024 | 4860 | 0.080 |
Why?
|
Exercise | 1 | 2024 | 5954 | 0.070 |
Why?
|
Fruit | 1 | 2013 | 1165 | 0.070 |
Why?
|
International Cooperation | 1 | 2014 | 1436 | 0.070 |
Why?
|
Liver Neoplasms | 1 | 2023 | 4363 | 0.070 |
Why?
|
Vegetables | 1 | 2013 | 1199 | 0.070 |
Why?
|
Creatinine | 1 | 2013 | 1917 | 0.070 |
Why?
|
Odds Ratio | 2 | 2016 | 9684 | 0.070 |
Why?
|
Rural Population | 1 | 2016 | 2325 | 0.060 |
Why?
|
HIV | 1 | 2013 | 1597 | 0.060 |
Why?
|
Cross-Sectional Studies | 2 | 2024 | 26395 | 0.060 |
Why?
|
Socioeconomic Factors | 1 | 2019 | 7861 | 0.060 |
Why?
|
Anti-Bacterial Agents | 1 | 2024 | 7478 | 0.060 |
Why?
|
Sex Factors | 1 | 2019 | 10633 | 0.060 |
Why?
|
Adipose Tissue | 1 | 2017 | 3335 | 0.060 |
Why?
|
Survival Rate | 1 | 2019 | 12873 | 0.060 |
Why?
|
Carcinoma | 1 | 2016 | 2340 | 0.060 |
Why?
|
Adolescent | 5 | 2022 | 89244 | 0.060 |
Why?
|
Gastrointestinal Diseases | 1 | 2013 | 1204 | 0.060 |
Why?
|
Biopsy | 1 | 2016 | 6805 | 0.060 |
Why?
|
Prognosis | 3 | 2019 | 30046 | 0.050 |
Why?
|
Papillomavirus Infections | 1 | 2015 | 1640 | 0.050 |
Why?
|
Multivariate Analysis | 2 | 2013 | 12095 | 0.050 |
Why?
|
Hepatitis C Antibodies | 1 | 2022 | 151 | 0.050 |
Why?
|
Registries | 1 | 2018 | 8384 | 0.050 |
Why?
|
Oxidative Stress | 1 | 2013 | 3139 | 0.050 |
Why?
|
Prospective Studies | 3 | 2016 | 54962 | 0.050 |
Why?
|
Hepatitis B Surface Antigens | 1 | 2022 | 294 | 0.050 |
Why?
|
Child | 2 | 2020 | 80960 | 0.050 |
Why?
|
Treatment Outcome | 2 | 2019 | 65480 | 0.040 |
Why?
|
Antigens, Surface | 1 | 2022 | 1616 | 0.040 |
Why?
|
Teaching Rounds | 1 | 2021 | 282 | 0.030 |
Why?
|
Hepacivirus | 1 | 2022 | 1344 | 0.030 |
Why?
|
Epstein-Barr Virus Nuclear Antigens | 1 | 2016 | 158 | 0.030 |
Why?
|
Seroepidemiologic Studies | 1 | 2016 | 405 | 0.030 |
Why?
|
Blood Transfusion | 1 | 2021 | 1309 | 0.030 |
Why?
|
Antitubercular Agents | 1 | 2023 | 1397 | 0.030 |
Why?
|
Hepatomegaly | 1 | 2013 | 84 | 0.030 |
Why?
|
Anti-Retroviral Agents | 1 | 2023 | 1795 | 0.030 |
Why?
|
Splenomegaly | 1 | 2013 | 192 | 0.030 |
Why?
|
Cooking | 1 | 2015 | 327 | 0.030 |
Why?
|
Asia | 1 | 2014 | 630 | 0.030 |
Why?
|
Molecular Epidemiology | 1 | 2014 | 473 | 0.020 |
Why?
|
Antigens, Viral | 1 | 2016 | 996 | 0.020 |
Why?
|
Esophageal and Gastric Varices | 1 | 2013 | 215 | 0.020 |
Why?
|
Hypertension, Portal | 1 | 2013 | 230 | 0.020 |
Why?
|
Escherichia coli | 1 | 2023 | 4213 | 0.020 |
Why?
|
Tobacco Smoke Pollution | 1 | 2015 | 828 | 0.020 |
Why?
|
Recurrence | 1 | 2021 | 8513 | 0.020 |
Why?
|
Stomach | 1 | 2013 | 702 | 0.020 |
Why?
|
Observer Variation | 1 | 2014 | 2623 | 0.020 |
Why?
|
Atrophy | 1 | 2013 | 1647 | 0.020 |
Why?
|
Confidence Intervals | 1 | 2013 | 2932 | 0.020 |
Why?
|
Antibodies, Bacterial | 1 | 2013 | 1478 | 0.020 |
Why?
|
Colonoscopy | 1 | 2014 | 1410 | 0.020 |
Why?
|
Linear Models | 1 | 2014 | 5891 | 0.010 |
Why?
|
Practice Guidelines as Topic | 1 | 2021 | 7460 | 0.010 |
Why?
|
Cause of Death | 1 | 2014 | 3721 | 0.010 |
Why?
|
Liver Cirrhosis | 1 | 2013 | 1962 | 0.010 |
Why?
|
Comorbidity | 1 | 2017 | 10592 | 0.010 |
Why?
|
Animals | 2 | 2023 | 169335 | 0.010 |
Why?
|
Time Factors | 1 | 2014 | 40261 | 0.010 |
Why?
|
Concepts
(175)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(8)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_